Calicine Tablets (Calidino-genase)

Adult dose

Administer 30-150 I.U. per day orally in 3 divided doses. The dose may be adjusted appropriately according to age and symptoms.

This medication should not be used in patients who have just experienced a cerebral hemorrhage or who have bleeding. Additionally, since this medication contains lactose, it should not be administered to patients with galactose intolerance, Lapp lactase deficiency, or glucose-galactose malabsorption syndromes. Caution is advised as allergic reactions may occur while using this medication. Discontinue use immediately if rash or itching develops. Rarely, symptoms of rapid heartbeat may occur, so consult a physician if this happens. It may affect the gastrointestinal system, causing symptoms such as abdominal discomfort, nausea, vomiting, loss of appetite, abdominal pain, diarrhea, or constipation. Furthermore, during the use of this medication, symptoms such as warmth, headache, heaviness in the head, drowsiness, or fatigue may rarely occur, so caution is necessary. For the elderly, the physical function may be weak; therefore, the dosage of this medication should be reduced or used with special caution.

• Rash
• itching
• palpitations
• discomfort in the stomach area
• nausea
• vomiting
• loss of appetite
• abdominal pain
• diarrhea
• constipation

This medication should be stored in a tightly sealed container that is not exposed to air, in a safe temperature range of 1 to 30 degrees Celsius. This helps maintain the effectiveness of the medication and prevent its deterioration.

Appearance

White round enteric-coated film-coated tablets

Package unit

30 tablets/bottle, 300 tablets/bottle